New prostate cancer treatment wins operations research award for Sloan-Kettering
Apr-30-2007
The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies last night and win an international competition for best project by an organization.
Onconome Announces Completion Of Breakthrough Research Study Highlighting New Blood Test For Prostate Cancer
Apr-25-2007
SEATTLE -- Onconome, Inc., a privately held Seattle based biotechnology company, today announced the publication of a groundbreaking research study conducted at The Johns Hopkins School of Medicine. The study relates to a newly discovered blood protein, ProstaMark(R) EPCA-2 (Early Prostate Cancer Antigen) that could change the way men are screened for prostate cancer, a disease which kills more than 25,000 men each year. The simple to use blood test detected an unprecedented 94 percent of men with prostate cancer and correctly identified 97 percent of men who don't have the disease, according to the Hopkins study. The study, conducted under the direction of Robert H. Getzenberg PhD, professor of urology and director of...
PSA Doubling Predicts Prostate Cancer Recurrence
Apr-25-2007
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent. Mayo's study, published in the April issue of Mayo Clinic Proceedings, concludes that patients with a PSA doubling time of less than three months after therapy are at imminent risk of death from prostate cancer. Patients with a doubling time of three...
New Blood Test for Prostate Cancer
Apr-26-2007
Title: New Blood Test for Prostate Cancer
Category: Health News
Created: 4/27/2007
Last Editorial Review: 4/27/2007
Category: Health News
Created: 4/27/2007
Last Editorial Review: 4/27/2007
Better Prostate Cancer Test May Be Near
Apr-26-2007
Title: Better Prostate Cancer Test May Be Near
Category: Health News
Created: 4/27/2007 2:00:00 AM
Last Editorial Review: 4/27/2007
Category: Health News
Created: 4/27/2007 2:00:00 AM
Last Editorial Review: 4/27/2007
A Promising New Screen for Prostate Cancer
Apr-27-2007
The prostate-specific antigen (PSA) test, used to screen for prostate cancer, is imperfect. It often flags conditions that turn out to be benign, resulting in unnecessary biopsies for more than a million men every year, and it misses other cases of cancer entirely. So the search is on for a better way to find the disease and avoid needless bother and pain for those who don't have it.
Group targets prostate cancer
Apr-22-2007
The Obediah Cole Foundation for will offer a series of free prostate cancer screenings with the goal of catching the disease early enough to be easily treated.
'I don't want it to sneak up on me'
Apr-28-2007
Charles Elkins always intended to be screened for prostate cancer, having lost a few friends to the illness.
Selenium May Fight Prostate Cancer
Apr-18-2007
BUFFALO, N.Y. -- A U.S. study suggests selenium might offer an intervention strategy for the treatment of prostate cancer. Yan Hu of the Roswell Park Cancer Institute said selenium, an effective chemopreventive agent for prostate cancer, has been found to down-regulate interleukin-6, of IL-6 -- a cytokine that induces the progression of the spread of androgen-independent prostate cancer cells. Most prostate cancer patients respond initially to anti-androgen therapy, but virtually all patients relapse due to the growth of androgen-independent tumor cells promoted by the overexpression of IL-6. Hu posits down-regulation of the cytokine by selenium might present an interventional strategy in prostate cancer therapy. H...
PSA Value Is a Poor Predictor of Prostate Cancer Outcome
Apr-16-2007
While prostate-specific antigen measurement remains an important monitoring tool, it poorly distinguishes those who will develop lethal prostate cancer from those at low or no risk for progression. (CME)
Medscape Medical News
Medscape Medical News
Studies From Oregon Health & Science University Update Current Data On Prostate Cancer Therapy
Apr-11-2007
Current study results from the report, "Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study," have been published. "Primary androgen suppression therapy for clinically localized prostate cancer is increasingly common in the United States despite a lack of supportive evidence for its use. We determined which demographic and clinical factors predict overall and cancer specific survival with this treatment strategy in patients enrolled in the Prostate Cancer Outcomes Study. In 1994 to 1995 the Prostate Cancer Outcomes Study recruited 3,533 men diagnosed with prostate cancer," investigators in the United State...
New Findings Reported From The Netherlands And Italy Describe Advances In Prostate Cancer
Apr-11-2007
New prostate cancer findings from the Netherlands and Italy described. Study 1: Scientists discuss in "Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis" new findings in prostate cancer. In this recently published article, scientists in Nijmegen, Netherlands conducted a study "To evaluate the potential benefit of semiautomated localization of prostate cancer using clustering analysis on three-dimensional (3-D) contrast-enhanced power Doppler images. Thirty patients with biopsy-proven prostate cancer and scheduled for radical prostatectomy underwent a 3-D contrast-enhanced power Doppler scan prior to surgery." "A 3-D ellipsoid model was manually fitted around th...
Prostate Cancer Treatments - What You Need To Know - Nurse's Prostate Cancer Report
Apr-10-2007
Many men, especially those later in life have made the decision with their doctors to simply watch and wait. Early prostate cancer is confined to the prostate gland itself; most of the patients with this type of cancer can live for years without any problems.Cancer that grows in the prostate gland is called prostate cancer. About one man in six will be diagnosed with prostate cancer during his lifetime, but only one man in 34 will die of the disease. Prostate cancer is the second leading cause o...
Prostate Cancer - Your Quick Guide
Apr-10-2007
The prostate gland is located just beneath the bladder and in front of the rectum. Although one man in six will be diagnosed with prostate cancer during his lifetime, only one man in 34 will die of the disease. About 80 percent of men who reach the age of 80 will have prostate cancer.Most men younger than 40 are rarely ever diagnosed with prostate cancer. Prostate cancer is normally a very slow growth cancer that can take many years before it becomes deadly. The most common cancer in American m...
Your Quick Guide To Facts About Prostate Cancer
Apr-10-2007
Prostate cancer is cancer that grows in the prostate gland. At an advanced age, the risks of surgery for prostate cancer or other more radical treatments may actually be worse than the disease itself. Detected in its earliest stages, prostate cancer can be effectively treated and cured.About one man in six will be diagnosed with prostate cancer during his lifetime, but only one man in 34 will die of the disease. The main job of the prostate gland is to make seminal fluid, the milky substance tha...
Get Checked For Prostate Cancer Now
Apr-10-2007
If you have prostate cancer, are concerned about getting it, or if you're looking out for the health of someone you love, this article can help. In most men, prostate cancer grows very slowly: most men will never know they have the condition. Prostate cancer is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over 75 years old.Prostate cancer is normally a slow growth cancer that can take years before it becomes deadly....
Prostate Cancer Book Delivers Hope
Apr-11-2007
CHARLOTTESVILLE, Va. -- Rivanna Health Publications recently announced the publication of prostate cancer specialist and survivor, Dr. Charles "Snuffy" Myers's newest weapon in the fight against prostate cancer: The book "Beating Prostate Cancer: Hormonal Therapy and Diet" is a crucial resource for effecting remission with androgen blockade alone or in tandem with radiation or surgery. Utilizing a simple golf metaphor to outline the twists and turns of diagnosis and treatment, the book addresses metastatic patients, the newly diagnosed, and healthcare professionals alike. Topics include: Hormonal Therapy Regimens, Diet/Lifestyle, Radiation, Surgery, and many others. "Prostate cancer is like golf," notes Myers. "You nee...
Best Prostate Cancer Tips
Apr-10-2007
The prostate gland is part of the male reproductive system. Cancer that grows in the prostate gland is called prostate cancer. Prostate cancer is the second leading cause of cancer deaths among men in the U.S.Men, who are younger than 40, are rarely ever diagnosed with prostate cancer. Men have traditionally been less likely to seek medical attention than women, especially for minor problems, which often serve as warning signs for more serious underlying illness. The most common cancer in Americ...
Prostate Cancer Worries That Men Don't Want To Admit To
Apr-10-2007
If you have prostate cancer, or are concerned about getting it, or if you're looking out for the health of someone you love, this article can help. In most men, it grows very slowly: most men will never know they have the condition. The most common cancer in American men, except for skin cancer, is prostate cancer.Detected in its early stages, prostate cancer can be effectively treated and cured. The prostate gland is located directly beneath the bladder and in front of the rectum. The main job...
Pioneering Prostate Cancer Surgeon Arnon Krongrad, MD Appointed Medical Advisor to the American Prostate Cancer Initiative
Apr-10-2007
Arnon Krongrad, MD, CEO of the Krongrad Institute, has been appointed the founding Medical Advisor to the not-for-profit American Prostate Cancer Initiative. The appointment comes as the APCI gears up to launch a first-of-kind national prostate cancer awareness campaign in time for Father's Day. (PRWeb Mar 21, 2007)
Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1Ib3JyLUNvdXAtRmFsdS1NYWduLVplcm8=
Do You Think You Have A Prostate Problem Or Possibly Prostate Cancer?
Apr-10-2007
Prostate cancer is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over 75 years old. At an advanced age, the risks of surgery for prostate cancer or other more radical treatments may actually be worse than the disease. The main job of the prostate gland is to make seminal fluid, the milky substance that transports sperm.The prostate gland is located directly beneath the bladder and in front of the rectum. In most men, ...
PSA doubling predicts prostate cancer recurrence
Apr-08-2007
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent.
Johns Hopkins Prostate Cancer Treatment Special Report Released
Apr-10-2007
The specialists at Johns Hopkins's world-renowned James Buchanan Brady Urological Institute have just released "Choosing the Right Treatment for Your Prostate Cancer" in order to benefit the more than 230,000 men who will receive a diagnosis of prostate cancer this year. (PRWeb Mar 27, 2007)
Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1FbXB0LVRoaXItRmFsdS1NYWduLVplcm8=
Links Between Prostate Cancer Treatment, Periodontal Disease
Apr-10-2007
Scientists at the University of Pittsburgh School of Dental Medicine have found that men receiving hormone treatments for prostate cancer are much more likely to show gum disease than men who do not receive hormone treatments for prostate cancer. (PRWeb Apr 5, 2007)
Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/UHJvZi1TcXVhLVNpbmctQ3Jhcy1NYWduLVplcm8=
Veterinary scientists explore poultry virus as cancer killer
Apr-08-2007
Virologists in the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech are looking at how a genetically modified variant of Avian Newcastle disease virus can treat human prostate cancer. The work is the first to alter Newcastle disease virus through a reverse genetic system to target prostate cancer specifically.
Measuring calcium intake can help to identify osteoporosis in men with prostate cancer
Apr-09-2007
Study of 372 men with prostate cancer shows higher than average link with osteoporosis, regardless of whether hormone therapy or surgery is used. 49 percent of men had osteoporosis and only seven percent consumed recommended daily intake of calcium.
Identifying Osteoporosis In Men With Prostate Cancer
Apr-11-2007
Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to a recent study.
Living on Earth: New Studies Link Asthma, Prostate Cancer to Toxic Chemicals
Apr-14-2007
Living on Earth: New Studies Link Asthma, Prostate Cancer to Toxic Chemicals
CURWOOD: Dr. Myers I know the study didn’t look at this at all but the asthma epidemic is really big in cities and really big among poor people. What questions would you want to ask as a researcher to link that prevalence of [...]
Low Education Predicts Lower Quality of Life for Prostate Cancer Patients
Apr-11-2007
Among men who have received similar treatments for prostate cancer, those with less education, particularly those who did not graduate from high school, experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC).
Soy Protective Against Localized Prostate Cancer, But Not Advanced Prostate Cancer
Apr-04-2007
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer. The prospective study of 43,509 men, published in the March issue of Cancer Epidemiology, Biomarkers & Prevention, suggests that the effects of isoflavones on prostate cancer development may differ according to disease stage, say researchers at the National Cancer Center in Japan. One possible explanation is that isoflavones may delay the progression of latent prostate cancer only; on...
Research From The United States And Canada Yields New Prostate Cancer Findings
Apr-04-2007
Prostate cancer is the focus of recent research from the United States and Canada. Study 1: Researchers detail in "High bone density is associated with prostate cancer in older Afro-Caribbean men: Tobago prostate survey," new data in prostate cancer. In this recently published article, scientists in the United States conducted a study "To test the hypothesis that bone mineral density (BMD), a possible surrogate of lifetime exposure to hormone/growth factor/vitamin D/calcium exposure, is higher in prostate cancer cases than controls. Hip BMD was measured by dual X-ray absorptiometry in 222 Afro-Caribbean screening-detected prostate cancer cases and 1,503 screened non-cases, aged 45-79, in the population-based Tobago Prostate Survey." "...
PSA May Be Poor Predictor of Lethal Prostate Cancer
Apr-04-2007
Title: PSA May Be Poor Predictor of Lethal Prostate Cancer
Category: Health News
Created: 4/5/2007 2:00:00 AM
Last Editorial Review: 4/5/2007
Category: Health News
Created: 4/5/2007 2:00:00 AM
Last Editorial Review: 4/5/2007
Hormone Therapy for Advanced Prostate Cancer Not for Everyone
Apr-02-2007
Title: Hormone Therapy for Advanced Prostate Cancer Not for Everyone
Category: Health News
Created: 4/3/2007 2:00:00 AM
Last Editorial Review: 4/3/2007
Category: Health News
Created: 4/3/2007 2:00:00 AM
Last Editorial Review: 4/3/2007
New Study May Help Doctors Select Prostate Cancer Treatments
Apr-06-2007
The work comparing interstitial brachytherapy and radical prostatectomy for low-risk localized prostate cancer shows that the 2 treatments share a similar cost profile, but have varying side effects and a different impact on quality of life.
Medscape Medical News
Allison Gandey
Medscape Medical News
Allison Gandey
Cleveland will test new prostate cancer drug
Apr-05-2007
Cleveland BioLabs has said it intends to begin a phase II efficacy study for Curaxin CBLC102 in advanced, hormone-refractory prostate cancer after the criterion for initiation was met.
2 Rutgers College Of Nursing Professors Study Patients With Prostate Cancer
Apr-04-2007
Main Category: Prostate / News Article Date: 04 Apr 2007 - 17:00 PDT Two Rutgers College of faculty members are conducting a study to develop and test a targeted intervention to reduce ...
Cleveland BioLabs Phase II Hormone-Refractory Prostate Cancer Trial Advances to Next Phase
Apr-06-2007
Cleveland BioLabs, Inc. , announced today that its Phase II efficacy study for Curaxin CBLC102 in advanced, hormone-refractory has progressed to the next phase.